Travere Therapeutics (RTRX) Short Interest Ratio & Short Volume

Short interest is the volume of Travere Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 30th, traders have sold 4,810,000 shares of RTRX short. Learn More on Travere Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RTRX shares currently have a short interest ratio of 16.0. Learn More on Travere Therapeutics's short interest ratio.

Travere Therapeutics saw a increase in short interest in the month of October. As of October 30th, there was short interest totaling 4,810,000 shares, an increase of 1.7% from the previous total of 4,730,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Travere Therapeutics: Zymeworks Inc. (3.24%), Aerovate Therapeutics, Inc. (21.72%), PyroGenesis Canada Inc. (0.14%), Aadi Bioscience, Inc. (6.58%), Eagle Pharmaceuticals, Inc. (0.46%), Actinium Pharmaceuticals, Inc. (4.54%), NanoViricides, Inc. (1.62%), AEON Biopharma, Inc. (5.67%), China Pharma Holdings, Inc. (2.27%), Orgenesis Inc. (0.13%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.15 billion), Aon plc ($3.50 billion), Snap Inc. ($3.18 billion), Analog Devices, Inc. ($2.90 billion), The Clorox Company ($2.87 billion), Uber Technologies, Inc. ($2.01 billion), The Kroger Co. ($1.86 billion), International Flavors & Fragrances Inc. ($1.80 billion), Moderna, Inc. ($1.80 billion), and Simon Property Group, Inc. ($1.72 billion). View all of the most shorted stocks.

Short selling RTRX is an investing strategy that aims to generate trading profit from Travere Therapeutics as its price is falling. RTRX shares are trading down $0.40 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Travere Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RTRX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RTRX, twice per month. The most recent reporting period available is October, 30 2020.